Comerica Bank
- SEC CIK
- 0000901541
- Latest filing
- Jan 29, 2026
ENTA holding history
Enanta Pharmaceuticals Inc in every 13F filed by Comerica Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENTA overviewAll 13F holders of ENTAFull Q4 2025 holdings
- Shares (Q4 2025)
- 367
- Value
- $5.79K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 367 | $5.79K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 367 | $4.39K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 367 | $2.77K | <0.1% | −583−61.4% | Reduced | Holders |
| Q1 2025 | 950 | $5.24K | <0.1% | +950 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −333−100.0% | Sold out | Holders |
| Q1 2024 | 333 | $5.81K | <0.1% | +333 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −75−100.0% | Sold out | Holders |
| Q3 2023 | 75 | $838 | <0.1% | −710−90.4% | Reduced | Holders |
| Q2 2023 | 785 | $0 | 0.0% | – | No prior filing | Holders |
| Q1 2023 | – | – | – | – | Not filed | Holders |
| Q4 2022 | 10,732 | $517.0K | <0.1% | −3,360−23.8% | Reduced | Holders |
| Q3 2022 | 14,092 | $641.0K | <0.1% | −730−4.9% | Reduced | Holders |
| Q2 2022 | 14,822 | $755.0K | <0.1% | −639−4.1% | Reduced | Holders |
| Q1 2022 | 15,461 | $1.17M | <0.1% | +445+3.0% | Added | Holders |
| Q4 2021 | 15,016 | $880.0K | <0.1% | −1,295−7.9% | Reduced | Holders |
| Q3 2021 | 16,311 | $1.21M | <0.1% | −544−3.2% | Reduced | Holders |
| Q2 2021 | 16,855 | $819.0K | <0.1% | −1,319−7.3% | Reduced | Holders |
| Q1 2021 | 18,174 | $914.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.